House Energy and Commerce Committee Holds Second Hearing on the 340B Drug Pricing Program

On October 11, 2017, the House Energy & Commerce’s Oversight and Investigations Subcommittee held a hearing entitled “Examining How Covered Entities Utilize the 340B Drug Pricing Program.” This was the Subcommittee’s second hearing of the year on the...
By: King & Spalding

King & Spalding